TrialThe Lancet. Oncology2026

Systemic therapy, gastrectomy, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy versus systemic therapy alone for gastric cancer with limited peritoneal metastases (PERISCOPE II): final results of a multicentre, randomised, controlled, phase 3 trial after an unplanned commissioned interim analysis.

Judith S E Quik et al.PubMed ↗Publisher ↗

No numbers read from the abstract.